Elsevier Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Rosenberg
    Rosenberg
  5. Iyer
    Iyer
  6. Solit
    Solit
  7. Feldman
    Feldman
  8. Morris
    Morris
  9. Slovin
    Slovin
  10. Voss
    Voss

Groups

  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)
  7. Urology (54)
  8. Hematologic Malignancies, Division of (49)
  9. Human Oncology and Pathogenesis Program (49)
  10. Department of Pathology and Laboratory Medicine (46)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (245)
  2. Meeting Abstract (120)
  3. Review (7)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)

More Groups

People
  1. Robert Motzer (89)
  2. Howard Scher (72)
  3. Dean Bajorin (50)
  4. Jonathan Rosenberg (39)
  5. David Solit (33)
  6. Gopakumar Iyer (33)

More People

Years
  1. 2025 (9)
  2. 2024 (31)
  3. 2023 (12)
  4. 2022 (18)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. European Journal of Cancer (96)
  2. Clinical Genitourinary Cancer (63)
  3. Urologic Oncology: Seminars and Original Investigations (49)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Seminars in Oncology (41)
  6. Hematology/Oncology Clinics of North America (10)

More Publications

Results (384)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
    Journal Article

    Hammerich, K. H.; Donahue, T. F.; Rosner, I. L.; Cullen, J.; Kuo, H. C.; Hurwitz, L.; Chen, Y.; Bernstein, M.; Coleman, J.; Danila, D. C.; more...
    Urologic Oncology: Seminars and Original Investigations (2017)

    Fulltext@MSK | Save
  • Tumor stroma interaction is mediated by monocarboxylate metabolism
    Journal Article

    Patel, B. B.; Ackerstaff, E.; Serganova, I. S.; Kerrigan, J. E.; Blasberg, R. G.; Koutcher, J. A.; Banerjee, D.
    Experimental Cell Research (2017)

    Fulltext@MSK | Save
  • Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers
    Meeting Abstract

    Yap, T. A.; Krebs, M. G.; Postel-Vinay, S.; Bang, Y. J.; El-Khoueiry, A.; Abida, W.; Harrington, K.; Sundar, R.; Carter, L.; Castanon-Alvarez, E.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)
    Meeting Abstract

    Meric-Bernstam, F.; Tannir, N.; Harding, J.; Voss, M.; Mier, J.; DeMichele, A.; Munster, P.; Patel, M.; Iliopoulos, O.; Owonikoko, T.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    Meeting Abstract

    Sanford, N. N.; Chen, M. H.; Loffredo, M.; Renshaw, A.; Kantoff, P. W.; D'Amico, A. V.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
    Journal Article

    Bambury, R. M.; Rathkopf, D. E.
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
    Journal Article

    Milowsky, M. I.; Galsky, M. D.; Morris, M. J.; Crona, D. J.; George, D. J.; Dreicer, R.; Tse, K.; Petruck, J.; Webb, I. J.; Bander, N. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • Clinical evaluation of cisplatin sensitivity of germline polymorphisms in neoadjuvant chemotherapy for urothelial cancer
    Journal Article

    O'Donnell, P. H.; Alanee, S.; Stratton, K. L.; Garcia-Grossman, I. R.; Cao, H.; Ostrovnaya, I.; Plimack, E. R.; Manschreck, C.; Ganshert, C.; Smith, N. D.; more...
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Outcomes in patients with metastatic renal cell carcinoma who develop everolimus-related hyperglycemia and hypercholesterolemia: Combined subgroup analyses of the RECORD-1 and REACT Trials
    Journal Article

    Bono, P.; Oudard, S.; Bodrogi, I.; Hutson, T. E.; Escudier, B.; Machiels, J. P.; Thompson, J. A.; Figlin, R. A.; Ravaud, A.; Basaran, M.; more...
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Expression levels of DNA damage repair proteins are associated with overall survival in platinum-treated advanced urothelial carcinoma
    Journal Article

    Mullane, S. A.; Werner, L.; Guancial, E. A.; Lis, R. T.; Stack, E. C.; Loda, M.; Kantoff, P. W.; Choueiri, T. K.; Rosenberg, J.; Bellmunt, J.
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save